Completely unexpectedly, the enzyme ceramidase emerges as a new target structure for the therapy of SARS-CoV-2 infections. This is reported by Würzburg researchers in "Cells".
The Free State of Bavaria is funding a new research project on quantum sensors with three million euros. Among other things, it aims to further improve molecular and medical imaging.
The Bosch Health Campus (BHC) in Stuttgart and the Institute for Management in Medicine and Health Sciences (IMG) at the University of Bayreuth have agreed to engage in scientific cooperation. In future, research projects on medical management, leadership, and digitalisation will be developed and implemented in partnership. Joint studies on these topics will be publicly accessible and will flow into health economics study programmes at both institutions.
Researchers at the University of Würzburg develop the "photoswitching fingerprint analysis". A unique technology that for the first time allows the analysis of molecular processes and the regulation of individual proteins in living cells with sub-10 nm spatial resolution. The application ranges from biological to medical research and has been published in the renowned journal Nature Methods.
Poxviruses pose a threat to humanity that should be taken seriously, as the current outbreak of monkeypox shows. A research team from the University of Würzburg is now working on the development of new drugs.
Long periods in space damage bone structure irreparably in some cases and can make parts of the human skeleton age prematurely by up to 10 years. This is what a sport scientist at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) has now discovered in conjunction with other researchers from Germany, Canada and the USA. Adapted training programs in conjunction with medication could provide better protection for astronauts on future space missions. The researchers have published their findings, which will now be also be used for treating rheumatic conditions in clinical practice, in the scientific journal Nature Scientific Reports.
At the current time, there is no cure for amyotrophic lateral sclerosis (ALS). Things may be about to change, however. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and the University of California San Diego (UCSD) have identified a protein that already displays pathological characteristics at an early stage of the neurological disease. The team has published their discovery, that could lead to a new approach for treating the disease, in the journal “Acta Neuropathologica”.
More and more bacteria are becoming resistant to antibiotics. Bacteriophages are one alternative in the fight against bacteria: These viruses attack very particular bacteria in a highly specific way. Now a Munich research team has developed a new way to produce bacteriophages efficiently and without risk.
A research project at Landshut University of Applied Sciences wants to improve the manufacturing process for protective face masks in Germany and the filter effect of the masks.
Findings of the LMU University Hospital Munich, the German Center for Infection Research (DZIF) and the U.S. Military HIV Research Program in collaboration with the African Cohort Study (AFRICOS) Group suggest that blood-based biomarkers can often detect incipient Tuberculosis (TB) between six to twelve months earlier in people living with HIV before a sputum-based TB diagnosis is possible. The detection of TB disease activity within the body using sputum-independent biomarkers could provide a window of opportunity to identify active TB earlier. This would allow to directly start medical treatment and thus to prevent progression and transmission of the disease.
This website uses cookies and the Matomo web analysis tool. By continuing to browse you agree to our use of cookies. Change your settings here. More information.